Galapagos NV NASDAQ:GLPG

Founder-led company

Galapagos NV stock price today

$32.1
+4.80
+17.58%
Financial Health
0
1
2
3
4
5
6
7
8
9

Galapagos NV stock price monthly change

+1.11%
month

Galapagos NV stock price quarterly change

+1.11%
quarter

Galapagos NV stock price yearly change

-32.77%
year

Galapagos NV key metrics

Market Cap
1.75B
Enterprise value
1.86B
P/E
-10.47
EV/Sales
3.22
EV/EBITDA
27.85
Price/Sales
3.70
Price/Book
0.79
PEG ratio
-0.15
EPS
0.95
Revenue
123.28M
EBITDA
-51.61M
Income
278.71M
Revenue Q/Q
-65.09%
Revenue Y/Y
-77.49%
Profit margin
0.96%
Oper. margin
-82.54%
Gross margin
98.46%
EBIT margin
-82.54%
EBITDA margin
-41.86%
Sign up &
create your own Smart Feed

Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.

Sign up for free

Galapagos NV stock price history

Galapagos NV stock forecast

Galapagos NV financial statements

Galapagos NV (NASDAQ:GLPG): Profit margin
Jun 2023 149.95M 5.10M 3.4%
Sep 2023 120.02M 25.83M 21.52%
Dec 2023 -209.12M 157.55M -75.34%
Mar 2024 62.43M 90.22M 144.51%
Galapagos NV (NASDAQ:GLPG): Analyst Estimates
Mar 2024 62.43M 90.22M 144.51%
Sep 2025 60.13M 5.18M 8.63%
Dec 2025 69.93M -13.04M -18.65%
Dec 2025 60.13M 5.18M 8.63%
  • Analysts Price target

  • Financials & Ratios estimates

Galapagos NV (NASDAQ:GLPG): Earnings per share (EPS)
2023-05-04 -0.87 0.43
2023-08-03 1.08 -0.31
Galapagos NV (NASDAQ:GLPG): Debt to assets
Jun 2023 4522340000 1.93B 42.86%
Sep 2023 4451336000 1.82B 41.11%
Dec 2023 4357396000 1.56B 35.84%
Mar 2024 4361379000 1.46B 33.62%
Galapagos NV (NASDAQ:GLPG): Cash Flow
Jun 2023 -125.41M 100.90M -1.55M
Sep 2023 -118.81M 182.53M -2.06M
Dec 2023 -66.86M 76.40M -1.19M
Mar 2024 -117.78M 25.01M -1.16M

Galapagos NV alternative data

Galapagos NV (NASDAQ:GLPG): Employee count
Aug 2023 1,338
Sep 2023 1,233
Oct 2023 1,233
Nov 2023 1,233
Dec 2023 1,338
Jan 2024 1,338
Feb 2024 1,338
Mar 2024 1,338
Apr 2024 1,338
May 2024 1,123
Jun 2024 1,123
Jul 2024 1,123

Galapagos NV other data

24.39% +3.66%
of GLPG is owned by hedge funds
12.71M +1.90M
shares is hold by hedge funds
Patent
Application
Filling date: 27 May 2022 Issue date: 8 Sep 2022
Application
Filling date: 25 May 2020 Issue date: 28 Jul 2022
Application
Filling date: 12 Nov 2021 Issue date: 21 Jul 2022
Application
Filling date: 24 Mar 2020 Issue date: 14 Jul 2022
Application
Filling date: 21 Apr 2020 Issue date: 30 Jun 2022
Application
Filling date: 24 Mar 2020 Issue date: 23 Jun 2022
Application
Filling date: 3 Sep 2021 Issue date: 2 Jun 2022
Grant
Filling date: 2 Jun 2020 Issue date: 31 May 2022
Grant
Filling date: 26 Nov 2018 Issue date: 24 May 2022
Application
Filling date: 17 Feb 2020 Issue date: 12 May 2022
Insider Compensation
Mr. Onno Van De Stolpe (1959) Co-Founder, Chairman of the Management Board, MD & Chief Executive Officer
$1,000,000
Mr. Bart Filius M.B.A., MBA (1970) Pres, Chief Operating Officer & Member of Management Board
$642,120
Dr. Walid Abi-Saab (1965) Chief Medical Officer & Member of Management Board
$613,110
Dr. Andre Hoekema (1957) Chief Bus. Officer & Member of Management Board
$578,000
Saturday, 7 December 2024
globenewswire.com
Tuesday, 5 November 2024
globenewswire.com
Thursday, 31 October 2024
seekingalpha.com
Wednesday, 30 October 2024
globenewswire.com
Monday, 7 October 2024
globenewswire.com
Tuesday, 1 October 2024
businesswire.com
Monday, 30 September 2024
globenewswire.com
Monday, 16 September 2024
globenewswire.com
Tuesday, 3 September 2024
globenewswire.com
Monday, 26 August 2024
investors.com
Friday, 23 August 2024
seekingalpha.com
zacks.com
globenewswire.com
Tuesday, 20 August 2024
globenewswire.com
Friday, 2 August 2024
seekingalpha.com
Thursday, 1 August 2024
prnewswire.com
globenewswire.com
Friday, 14 June 2024
globenewswire.com
Thursday, 30 May 2024
newsfilecorp.com
globenewswire.com
Thursday, 16 May 2024
globenewswire.com
Wednesday, 15 May 2024
globenewswire.com
Saturday, 4 May 2024
Seeking Alpha
Wednesday, 3 April 2024
Zacks Investment Research
Monday, 18 March 2024
Zacks Investment Research
Friday, 15 December 2023
Zacks Investment Research
Wednesday, 13 December 2023
Zacks Investment Research
Sunday, 5 November 2023
Seeking Alpha
Friday, 4 August 2023
Seeking Alpha
Saturday, 6 May 2023
Seeking Alpha
  • What's the price of Galapagos NV stock today?

    One share of Galapagos NV stock can currently be purchased for approximately $32.1.

  • When is Galapagos NV's next earnings date?

    Unfortunately, Galapagos NV's (GLPG) next earnings date is currently unknown.

  • Does Galapagos NV pay dividends?

    No, Galapagos NV does not pay dividends.

  • How much money does Galapagos NV make?

    Galapagos NV has a market capitalization of 1.75B and it's past years’ income statements indicate that its last revenue has decreased compared to the previous period by 52.56% to 239.72M US dollars. Galapagos NV earned 211.7M US dollars in net income (profit) last year or -$0.31 on an earnings per share basis.

  • What is Galapagos NV's stock symbol?

    Galapagos NV is traded on the NASDAQ under the ticker symbol "GLPG".

  • What is Galapagos NV's primary industry?

    Company operates in the Healthcare sector and Biotechnology industry.

  • How do i buy shares of Galapagos NV?

    Shares of Galapagos NV can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

  • Who are Galapagos NV's key executives?

    Galapagos NV's management team includes the following people:

    • Mr. Onno Van De Stolpe Co-Founder, Chairman of the Management Board, MD & Chief Executive Officer(age: 66, pay: $1,000,000)
    • Mr. Bart Filius M.B.A., MBA Pres, Chief Operating Officer & Member of Management Board(age: 55, pay: $642,120)
    • Dr. Walid Abi-Saab Chief Medical Officer & Member of Management Board(age: 60, pay: $613,110)
    • Dr. Andre Hoekema Chief Bus. Officer & Member of Management Board(age: 68, pay: $578,000)
  • Is Galapagos NV founder-led company?

    Yes, Galapagos NV is a company led by its founder Mr. Onno Van De Stolpe.

  • How many employees does Galapagos NV have?

    As Jul 2024, Galapagos NV employs 1,123 workers, which is 16% less then previous quarter.

  • When Galapagos NV went public?

    Galapagos NV is publicly traded company for more then 13 years since IPO on 27 Feb 2012.

  • What is Galapagos NV's official website?

    The official website for Galapagos NV is glpg.com.

  • How can i contact Galapagos NV?

    Galapagos NV can be reached via phone at +32 15 34 29 00.

Galapagos NV company profile:

Galapagos NV

glpg.com
Exchange:

NASDAQ

Full time employees:

1,123

Industry:

Biotechnology

Sector:

Healthcare

Galapagos NV, an integrated biopharmaceutical company, engages in the discovery, development, and commercialization of various medicines for high unmet medical need. Its pipeline products include filgotinib, a JAK1 inhibitor that is in various phases of clinical trials for the treatment of rheumatoid arthritis, Crohn's disease, ulcerative colitis, small bowel CD, fistulizing CD, ankylosing spondylitis, psoriatic arthritis, and uveitis. The company's pipeline products also comprise GLPG1972 that has completed Phase 2b trial for treating osteoarthritis; Toledo molecules, including GLPG3970, GLPG4399, and GLPG4876 for inflammation; and GLPG4716 and Ziritaxestat to treat idiopathic pulmonary fibrosis. In addition, its other pipeline products include GLPG2737, a cystic fibrosis transmembrane conductance regulator that is in Phase 2 clinical trials to treat patients with autosomal dominant polycystic kidney disease; and GLPG0555, a JAK1 inhibitor, which is in Phase 1b for treatment of patients with osteoarthritis. The company has collaboration agreements with Gilead Sciences, Inc.; AbbVie S.à r.l.; and Novartis Pharma AG. Galapagos NV was incorporated in 1999 and is headquartered in Mechelen, Belgium.

Generaal De Wittelaan L11 A3
Mechelen, 2800

CIK: 0001421876
ISIN: US36315X1019
CUSIP: 36315X101